Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

[Erythroferrone, an erythroid regulator of iron metabolism].

Kautz L.

Med Sci (Paris). 2014 Oct;30(10):834-6. doi: 10.1051/medsci/20143010005. Epub 2014 Oct 14. French. No abstract available.

2.

EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.

Jiang X, Gao M, Chen Y, Liu J, Qi S, Ma J, Zhang Z, Xu Y.

Blood Cells Mol Dis. 2016 May;58:45-51. doi: 10.1016/j.bcmd.2016.02.005. Epub 2016 Feb 19.

PMID:
27067488
3.

The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesis.

Guo S, Jiang X, Wang Y, Chen L, Li H, Li X, Jia Y.

Cell Signal. 2017 Oct;38:106-115. doi: 10.1016/j.cellsig.2017.07.002. Epub 2017 Jul 8.

PMID:
28697999
4.

Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.

Kautz L, Jung G, Du X, Gabayan V, Chapman J, Nasoff M, Nemeth E, Ganz T.

Blood. 2015 Oct 22;126(17):2031-7. doi: 10.1182/blood-2015-07-658419. Epub 2015 Aug 14.

5.

Identification of erythroferrone as an erythroid regulator of iron metabolism.

Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T.

Nat Genet. 2014 Jul;46(7):678-84. doi: 10.1038/ng.2996. Epub 2014 Jun 1.

6.

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.

Origa R, Cazzola M, Mereu E, Danjou F, Barella S, Giagu N, Galanello R, Swinkels DW.

Haematologica. 2015 May;100(5):e169-71. doi: 10.3324/haematol.2014.115733. Epub 2015 Jan 16. No abstract available.

7.

[The role of erythroferrone in iron metabolism: From experimental results to pathogenesis].

Vallet N; Club du Globule Rouge et du Fer.

Rev Med Interne. 2018 Mar;39(3):178-184. doi: 10.1016/j.revmed.2017.05.008. Epub 2017 Jun 27. Review. French.

PMID:
28666715
8.

Erythroferrone contributes to recovery from anemia of inflammation.

Kautz L, Jung G, Nemeth E, Ganz T.

Blood. 2014 Oct 16;124(16):2569-74. doi: 10.1182/blood-2014-06-584607. Epub 2014 Sep 5.

9.

Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Schmidt PJ, Fleming MD.

Hematol Oncol Clin North Am. 2014 Apr;28(2):387-401. doi: 10.1016/j.hoc.2013.11.004. Epub 2014 Jan 18. Review.

10.

Exogenous iron increases hemoglobin in beta-thalassemic mice.

Ginzburg YZ, Rybicki AC, Suzuka SM, Hall CB, Breuer W, Cabantchik ZI, Bouhassira EE, Fabry ME, Nagel RL.

Exp Hematol. 2009 Feb;37(2):172-83. doi: 10.1016/j.exphem.2008.10.004. Epub 2008 Dec 6.

PMID:
19059700
11.

Erythroferrone and matriptase-2 independently regulate hepcidin expression.

Aschemeyer S, Gabayan V, Ganz T, Nemeth E, Kautz L.

Am J Hematol. 2017 May;92(5):E61-E63. doi: 10.1002/ajh.24672. Epub 2017 Feb 24. No abstract available.

12.

Erythroferrone: the missing link in β-thalassemia?

Moura IC, Hermine O.

Blood. 2015 Oct 22;126(17):1974-5. doi: 10.1182/blood-2015-09-665596.

13.

Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.

Frýdlová J, Rychtarčíková Z, Gurieva I, Vokurka M, Truksa J, Krijt J.

PLoS One. 2017 Oct 26;12(10):e0186844. doi: 10.1371/journal.pone.0186844. eCollection 2017.

14.

Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.

Casu C, Oikonomidou PR, Chen H, Nandi V, Ginzburg Y, Prasad P, Fleming RE, Shah YM, Valore EV, Nemeth E, Ganz T, MacDonald B, Rivella S.

Blood. 2016 Jul 14;128(2):265-76. doi: 10.1182/blood-2015-10-676742. Epub 2016 May 6.

15.

Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210.

Sarakul O, Vattanaviboon P, Tanaka Y, Fucharoen S, Abe Y, Svasti S, Umemura T.

Blood Cells Mol Dis. 2013 Aug;51(2):98-103. doi: 10.1016/j.bcmd.2013.03.005. Epub 2013 Apr 24.

PMID:
23623309
16.
17.

Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.

Ramos P, Melchiori L, Gardenghi S, Van-Roijen N, Grady RW, Ginzburg Y, Rivella S.

Ann N Y Acad Sci. 2010 Aug;1202:24-30. doi: 10.1111/j.1749-6632.2010.05596.x.

18.

A Red Carpet for Iron Metabolism.

Muckenthaler MU, Rivella S, Hentze MW, Galy B.

Cell. 2017 Jan 26;168(3):344-361. doi: 10.1016/j.cell.2016.12.034. Review.

20.

The transcription factor ATOH8 is regulated by erythropoietic activity and regulates HAMP transcription and cellular pSMAD1,5,8 levels.

Patel N, Varghese J, Masaratana P, Latunde-Dada GO, Jacob M, Simpson RJ, McKie AT.

Br J Haematol. 2014 Feb;164(4):586-96. doi: 10.1111/bjh.12649. Epub 2013 Nov 16.

Supplemental Content

Support Center